Total Payments
$198,583
2024 Payments
$31,525
Companies
40
Transactions
496
Medicare Patients
22,668
Medicare Billing
$2.8M
Payment Breakdown by Category
Other$142,695 (71.9%)
Consulting$22,863 (11.5%)
Travel$21,841 (11.0%)
Food & Beverage$11,144 (5.6%)
Education$40.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $142,695 | 48 | 71.9% |
| Consulting Fee | $22,863 | 10 | 11.5% |
| Travel and Lodging | $21,841 | 55 | 11.0% |
| Food and Beverage | $11,144 | 379 | 5.6% |
| Education | $40.96 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $106,630 | 140 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $86,582 | 128 | $0 (2024) |
| Amgen Inc. | $781.97 | 37 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $509.78 | 35 | $0 (2024) |
| PFIZER INC. | $384.96 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $344.42 | 17 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $308.41 | 15 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $264.94 | 16 | $0 (2024) |
| ABIOMED | $251.09 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $243.96 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,525 | 101 | E.R. Squibb & Sons, L.L.C. ($30,418) |
| 2023 | $37,221 | 93 | E.R. Squibb & Sons, L.L.C. ($36,297) |
| 2022 | $33,738 | 54 | E.R. Squibb & Sons, L.L.C. ($33,070) |
| 2021 | $6,906 | 9 | E.R. Squibb & Sons, L.L.C. ($6,713) |
| 2020 | $162.80 | 11 | PFIZER INC. ($45.37) |
| 2019 | $11,710 | 57 | Novartis Pharmaceuticals Corporation ($10,827) |
| 2018 | $43,811 | 88 | Novartis Pharmaceuticals Corporation ($43,034) |
| 2017 | $33,509 | 83 | Novartis Pharmaceuticals Corporation ($32,525) |
All Payment Transactions
496 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Cardiology | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.82 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Genetic Disease | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.15 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.82 | General |
| 11/11/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Genetic Disease | ||||||
| 11/11/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $1.30 | General |
| Category: Genetic Disease | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Genetic Disease | ||||||
| 11/05/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Genetic Disease | ||||||
| 10/28/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.68 | General |
| 10/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.47 | General |
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Genetic Disease | ||||||
| 10/15/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Genetic Disease | ||||||
| 10/14/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $58.05 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $12.22 | General |
| 09/23/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.80 | General |
| 09/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.18 | General |
| Category: Cardiovascular | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 51 | 5,291 | 6,925 | $1.4M | $525,777 |
| 2022 | 51 | 5,166 | 9,350 | $1.6M | $628,522 |
| 2021 | 55 | 6,266 | 12,884 | $2.1M | $828,066 |
| 2020 | 56 | 5,945 | 12,611 | $2.1M | $805,648 |
Total Patients
22,668
Total Services
41,770
Medicare Billing
$2.8M
Procedure Codes
235
All Medicare Procedures & Services
235 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 744 | 847 | $183,231 | $77,353 | 42.2% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 22 | 22 | $117,524 | $46,070 | 39.2% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 40 | 40 | $118,160 | $45,418 | 38.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 297 | 298 | $123,107 | $41,729 | 33.9% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 63 | 126 | $100,548 | $38,950 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 214 | 230 | $67,898 | $30,120 | 44.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 182 | 189 | $78,435 | $25,810 | 32.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 171 | 174 | $70,296 | $23,206 | 33.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 120 | 120 | $50,400 | $19,219 | 38.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 263 | 267 | $40,313 | $14,006 | 34.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,069 | 1,325 | $45,050 | $13,437 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 221 | 229 | $33,663 | $13,104 | 38.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 99 | 139 | $29,607 | $12,884 | 43.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 81 | 324 | $36,612 | $12,272 | 33.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 34 | 34 | $32,708 | $11,016 | 33.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 163 | $24,287 | $10,204 | 42.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 59 | 59 | $30,444 | $10,196 | 33.5% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 83 | 104 | $21,632 | $7,530 | 34.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 55 | 56 | $21,392 | $7,448 | 34.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 46 | 46 | $17,894 | $6,317 | 35.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 33 | 66 | $15,576 | $5,651 | 36.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 104 | 105 | $14,910 | $5,428 | 36.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 69 | 73 | $11,242 | $4,732 | 42.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 61 | 200 | $12,600 | $4,013 | 31.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 28 | 203 | $10,962 | $3,591 | 32.8% |
About Dr. Ann Tong, MD
Dr. Ann Tong, MD is a Cardiovascular Disease healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902879323.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Tong, MD has received a total of $198,583 in payments from pharmaceutical and medical device companies, with $31,525 received in 2024. These payments were reported across 496 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($142,695).
As a Medicare-enrolled provider, Tong has provided services to 22,668 Medicare beneficiaries, totaling 41,770 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 235 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Gainesville, FL
- Active Since 02/08/2006
- Last Updated 04/25/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1902879323
Products in Payments
- ENTRESTO (Drug) $86,516
- CAMZYOS (Drug) $77,224
- ELIQUIS (Drug) $559.04
- Repatha (Biological) $481.90
- ONPATTRO (Drug) $376.10
- Corlanor (Drug) $290.07
- JARDIANCE (Drug) $284.59
- XARELTO (Drug) $264.94
- PRALUENT (Drug) $263.62
- Impella (Device) $251.09
- VERQUVO (Drug) $243.96
- LifeVest (Device) $195.95
- LIMFLOW SYSTEM (Device) $134.62
- AMVUTTRA (Drug) $133.68
- Barostim Neo System (Device) $123.76
- Cardiac Mapping System (Device) $123.17
- Cardiac Monitoring Suite (Device) $119.35
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $116.46
- Ozempic (Drug) $111.77
- VYNDAQEL (Drug) $110.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Gainesville
Dr. Juan Aranda, Md, MD
Cardiovascular Disease — Payments: $357,500
Cardiovascular Disease $357,500
Mudassar Ahmed, Mbbs, MBBS
Cardiovascular Disease — Payments: $337,874
Cardiovascular Disease $337,874
Dr. Matheen Khuddus, M.d, M.D
Cardiovascular Disease — Payments: $223,657
Cardiovascular Disease $223,657
Dr. Carl Pepine, Md, MD
Cardiovascular Disease — Payments: $195,635
Cardiovascular Disease $195,635
Dr. Michael Koren, M.d, M.D
Cardiovascular Disease — Payments: $193,105
Cardiovascular Disease $193,105
Keith March, M.d, M.D
Cardiovascular Disease — Payments: $176,239
Cardiovascular Disease $176,239